Noninvasive monitoring in a patient with SAH diagnosis treated with Cerebrolysin - case report and review of the literature.

K Kojder, K Jarosz, A Andrzejewska, K Kubiak, W Poncyljusz, J Sołek-Pastuszka

Journal: European review for medical and pharmacological sciences 2023;27(14):6843-6849

PMID: 37522695

Free Full Text on European Review for Medical and Pharmacological Sciences View on PubMed

Abstract

BACKGROUND

Subarachnoid hemorrhage (SAH) causes a high percentage of deaths and rehabilitation failures. Despite endovascular and surgery treatment algorithms, there is still no consensus on the guidelines for monitoring and neuroprotective treatment of patients.

CASE REPORT

We report a case of a patient with SAH treated endovascularly. The patient was hospitalized in the intensive care unit and monitored using Near Infrared Spectroscopy (NIRS) and Optic Nerve Diameters Assessment (ONDS).

CONCLUSIONS

Early and high-dose Cerebrolysin was used safely as neuroprotective treatment intravenously. The treatment using Cerebrolysin and additional monitoring was beneficial for the patient.

Address: Anesthesiology and Intensive Care Department, Pomeranian Medical University, Szczecin, Poland. [email protected].

DOI: 10.26355/eurrev_202307_33155

Link outs

Free resources

Full Text Sources:

https://www.europeanreview.org/article/33155

MeSH Terms: Humans, Subarachnoid Hemorrhage, Amino Acids, Spectroscopy, Near-Infrared, Neuroprotection